We are live on ! Find out more
BMGL

Basel Medical

9 hedge funds and large institutions have $70.2K invested in Basel Medical in 2025 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.07% less ownership

Funds ownership: 0.13%0.06% (-0.07%)

10% less funds holding

Funds holding: 109 (-1)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

87% less capital invested

Capital invested by funds: $525K → $70.2K (-$454K)

Holders
9
Holders Change
-1
Holders Change %
-10%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
1
Reduced
1
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
GSC
1
Ground Swell Capital
South Carolina
$16.5K +$41.5K +2,809 New
XT
2
XTX Topco
Cayman Islands
$14.9K +$37.4K +2,536 New
Citadel Advisors
3
Citadel Advisors
Florida
$12.1K -$84.1K -5,694 -73%
Jane Street
4
Jane Street
New York
$7.98K +$20K +1,357 New
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$7.49K +$18.8K +1,274 New
Renaissance Technologies
6
Renaissance Technologies
New York
$7.1K +$17.8K +1,208 New
UBS Group
7
UBS Group
Switzerland
$3.96K +$2.69K +182 +37%
BIA
8
Bell Investment Advisors
California
$122
Morgan Stanley
9
Morgan Stanley
New York
-$135K -6,191 Closed
MG
10
Marex Group
-$105K -4,909 Closed
VF
11
Virtu Financial
New York
-$61K -2,816 Closed
VPIM
12
Vanguard Personalized Indexing Management
California
-$40.2K -1,842 Closed
W
13
WealthCollab
Washington
-$1.74K -79 Closed
EWA
14
EverSource Wealth Advisors
Alabama
-$504 -23 Closed

BMGL Hedge Fund Activity: Q4 2025 in Review

9 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Basel Medical (BMGL) for Q4 2025, worth a combined $70.2K — down 87% from $525K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of BMGL and 5 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Ground Swell Capital, opening a new position worth an estimated $41.5K. The largest seller was Morgan Stanley, exiting entirely with an estimated $135K sold.

  • 9 institutional investors held Basel Medical (BMGL) as of Q4 2025, down from 10 in Q3 2025.
  • Funds reported $70.2K of Basel Medical stock for Q4 2025, down 87% quarter-over-quarter.
  • 5 funds opened new Basel Medical positions in Q4 2025 and 6 closed out, a net change of -1 holder.
  • The largest Basel Medical buyer in Q4 2025 was Ground Swell Capital, an estimated $41.5K added.
  • The largest Basel Medical seller in Q4 2025 was Morgan Stanley, an estimated $135K sold.

Based on aggregated 13F filings for Q4 2025.